Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

JSE/DCP stock hub

JSE/DCP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JSE/DCPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30.8B

Johannesburg Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

JSE/DCP

In the news

Latest news · JSE/DCP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.1

P25 11.2P50 16.2P75 17.1

Trailing P/E25

P25 6.4P50 15.9P75 23.4

ROE24.4

P25 -14P50 7.2P75 31.6

ROIC15.3

P25 9.2P50 15.3P75 38.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JSE/DCP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

ZAR

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Africa
Country code	ZA
Employees	20,000
Employees Change	1,300%
Employees Change Percent	6.95
Enterprise value	ZAc 35.9B
Exchange	Johannesburg Stock Exchange
Financial currency	ZAR
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	ZAE000227831
Last refreshed	2026-05-10
Market cap	ZAc 30.8B
Price	ZAc 3,598
Price currency	ZAc
Rev Per Employee	2,044,201.45x
Sector	Healthcare
Sic	5912
Symbol	jse/DCP
Website	https://dischemgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.01%
EV Earnings	29.05x
EV/EBIT	16.17x
EV/EBITDA	10.8x
EV/FCF	66.56x
EV/Sales	0.88x
FCF yield	1.75%
Forward P/E	25.09x
P/B ratio	5.46x
P/E ratio	25x
P/S ratio	0.75x
PE Ratio10 Y	27.91x
PE Ratio3 Y	25.77x
PE Ratio5 Y	25x
PEG ratio	2.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.37%
EBITDA Margin	6.49%
FCF margin	1.32%
Gross margin	22.4%
Gross Profit	ZAc 9.2B
Gross Profit Growth	4.07%
Gross Profit Growth Q	8.18%
Gross Profit Growth3 Y	3.68%
Gross Profit Growth5 Y	3.84%
Net Income	ZAc 1.2B
Net Income Growth	16.39%
Net Income Growth Q	9.59%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	7.86%
Net Income Growth5 Y	4.31%
Pretax Margin	4.21%
Profit Margin	3.02%
Profit Per Employee	ZAc 61,761
Profitable Years	12
ROA	7.31
Roa5y	7.07
ROCE	23.17
ROE	24.4
Roe5y	26.34
ROIC	15.33
Roic5y	15.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	14.74%
Cagr3y	12.93%
Cagr5y	9.63%
Div CAGR3	5.83%
Div CAGR5	12.99%
EPS Growth	16.33
EPS Growth Q	9.51
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	7.85
EPS Growth5 Y	4.35
FCF Growth	-36.02%
FCF Growth Q	62.58%
FCF Growth3 Y	-14.52%
FCF Growth5 Y	18.57%
OCF Growth	7.82%
OCF Growth Q	56.37%
OCF Growth10 Y	5.09%
OCF Growth3 Y	3.09%
OCF Growth5 Y	9.43%
Revenue Growth	7.62x
Revenue Growth Q	8.75x
Revenue Growth Quarters	22x
Revenue Growth Years	11x
Revenue Growth3 Y	4.06x
Revenue Growth5 Y	4.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ZAc 2.18
Assets	ZAc 19.4B
Cash	ZAc 418.3M
Current Assets	ZAc 11.6B
Current Liabilities	ZAc 9.9B
Debt	ZAc 5.4B
Debt EBITDA	ZAc 1.65
Debt Equity	ZAc 0.96
Debt FCF	ZAc 10.1
Equity	ZAc 5.6B
Interest Coverage	4.07
Liabilities	ZAc 13.7B
Long Term Assets	ZAc 7.8B
Long Term Liabilities	ZAc 3.8B
Net Cash	ZAc -5B
Net Cash By Market Cap	ZAc -16.31
Net Debt EBITDA	ZAc 1.89
Net Debt Equity	ZAc 0.89
Net Debt FCF	ZAc 9.33
Tangible Book Value	ZAc 4.1B
Tangible Book Value Per Share	ZAc 4.75
WACC	6.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.17
Inventory Turnover	4.23
Net Working Capital	ZAc 3B
Quick ratio	0.4
Working Capital	ZAc 1.7B
Working Capital Turnover	ZAc 23.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	15.75%
Dividend Growth Years	2%
Dividend per share	ZAc 0.59
Dividend Years	5
Dividend Yield	1.64%
Ex Div Date	2025-11-19
Last Dividend	ZAc 0.29
Payout Frequency	Semi-Annual
Payout Ratio	41.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	14.73%
200-day SMA	3,460.9
3Y total return	44.03%
50-day SMA	3,600.7
50-day SMA vs 200-day SMA	50over200
5Y total return	58.36%
All Time High	4,000
All Time High Change	-10.05%
All Time High Date	2024-11-14
All Time Low	1,650
All Time Low Change	118.06%
All Time Low Date	2020-07-30
ATR	96.57
Beta	0.35
Beta1y	0.13
Beta2y	0.16
Ch YTD	2.8
High	3,723
High52	3,900
High52 Date	2026-04-09
High52ch	-7.74%
Low	3,598
Low52	3,020
Low52 Date	2025-08-07
Low52ch	19.14%
Ma50ch	-0.07%
Price vs 200-day SMA	3.96%
RSI	46.3
RSI Monthly	56.28
RSI Weekly	52.7
Sharpe ratio	0.54x
Sortino ratio	1.05
Total Return	1.6%
Tr YTD	2.8
Tr1m	-5.07%
Tr1w	-0.14%
Tr3m	-0.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ZAc 2.2B
Operating Income Growth	4.42
Operating Income Growth Q	9.01
Operating Income Growth3 Y	7.28
Operating Income Growth5 Y	4.73
Operating margin	5.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	547,041,286%
Net Borrowing	-314,712,000
Shares Insiders	5.18%
Shares Institutions	68.22%
Shares Out	856,962,792
Shares Qo Q	0.06%
Shares Yo Y	0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ZAc 510.4M
Average Volume	765,975.2x
Bv Per Share	6.57
CAPEX	ZAc -1.5B
Ch1m	-5.07
Ch1w	-0.14
Ch1y	12.76
Ch3m	-0.11
Ch3y	37.38
Ch5y	46.44
Ch6m	4.26
Change	-1.56%
Change From Open	-1.56
Close	3,655
Days Gap	0
Depreciation Amortization	456,429,000
Dollar Volume	1,762,026,952
Earnings Date	2026-05-29
EBIT	ZAc 2.2B
EBITDA	ZAc 2.7B
EPS	ZAc 1.44
F Score	6
FCF	ZAc 539.1M
FCF EV Yield	1.5x
FCF Per Share	ZAc 0.63
Financing CF	-836,412,000
Fiscal Year End	February
Founded	1,978
Graham Number	14.58053
Graham Upside	-99.59
Income Tax	ZAc 439.2M
Investing CF	-1,599,895,000
Is Primary Listing	1
Last Earnings Date	2025-10-30
Last Report Date	2025-08-31
Lynch Fair Value	ZAc 7.2
Lynch Upside	-99.8
Ma150	3,527.4
Ma150ch	2%
Ma20	3,661.6
Ma20ch	-1.74%
Net CF	-370,377,000
Next Earnings Date	2026-05-29
Open	3,655
P FCF Ratio	57.19
P OCF Ratio	14.89
Payment Date	2025-11-24
Position In Range	0
Ppne	5,538,616,000
Price Date	2026-05-08
Price EBITDA	ZAc 11.62
Ptbv Ratio	7.57
Relative Volume	0.66x
Revenue	40,884,029,000x
SBC By Revenue	0.07x
Share Based Comp	28,745,000
Tax By Revenue	1.07x
Tax Rate	25.52%
Tr6m	5.14%
Volume	489,724
Z Score	4.16

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

JSE/DCP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.6%

$0.59 annual per share

Payout ratio

+42.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+13.0%

2 consecutive years of growth

Total shareholder yield

+1.6%

Next ex-dividend date: 2025-11-19

Performance

JSE/DCP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JSE/DCP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+68.2%

Share of float held by funds and institutions

Insider ownership

+5.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

JSE/DCP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.3

Neutral momentum band

Price vs 200-day MA

+4.0%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JSE/DCP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current jse/DCP stock rating?

jse/DCP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full jse/DCP analysis?

The full report lives at /stocks/jse/DCP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for jse/DCP?

The latest report frames jse/DCP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the jse/DCP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.